It's fair to say that Simon Finfer has had a rather large impact on ICU research in the past couple of decades.

A key member of the original ANZICS Clinical Trials Group, principle investigator for several major trials and the father of this particular meeting, first convened nearly 20 years ago.

In this interview from the CTG Noosa meeting, Simon chats about the upcoming PLUS trial, looking for evidence that buffered fluids for resuscitation of ICU patients improves outcomes compared with normal saline.

It's fair to say that Simon Finfer has had a rather large impact on ICU research in the past couple of decades.
A key member of the original ANZICS Clinical Trials Group, principle investigator for several major trials and the father of this particular meeting, first convened nearly 20 years ago.
In this interview from the CTG Noosa meeting, Simon chats about the upcoming PLUS trial, looking for evidence that buffered fluids for resuscitation of ICU patients improves outcomes compared with normal saline.

This podcast is dedicated to the hard-working doctors, nurses and allied health professionals striving for excellence

Osler Podcasts

This podcast is dedicated to the hard working doctors, nurses and allied health professionals who are continually striving for excellence in critical care.

Advertisement